GE HealthCare Technologies Inc.
GEHC · Nasdaq
Analyst Consensus
Analyst Ratings Synthesis
Consensus is Buy across 13 analysts, while the only supplied target statistic is a mean of $80. The low and high targets are not available, so the target cluster and spread cannot be measured, and no named analyst or firm is identified as most or least bullish. The evidence also contains no attributable target revisions during the week, preventing a supported conclusion about whether estimates moved higher or lower. The substantive disagreement visible in the record is therefore limited: the bullish case rests on renewed hospital demand for diagnostic and capital equipment, while the downside case reflects the absence of quantified evidence showing that the demand cycle is broad, durable, or sufficient to validate the consensus target.
